IBAT inhibitors, elastography and more
Cleveland Clinic specialists discuss challenges and opportunities for managing the disease
More accurate than existing noninvasive tests
Findings underscore need for early screening and close follow-up
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Method can eliminate need for liver biopsies in significant number of patients
Study finds a 43% lower risk of HCC in statin users
A quick review of several advances in risk assessment and treatment
Immune-mediated factors may be involved
The rising burden of NAFLD
A new disease to worry about in teens?